Oppenheimer & Co’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History
Bought
Maintained
Sold
Other funds holding ECAT
SCM
PCM
AAM
Oppenheimer & Co's ECAT Position: Q2 2026 in Review
Oppenheimer & Co reduced its BlackRock ESG Capital Allocation Term Trust (ECAT) stake by 1.5% in Q2 2026, selling an estimated $43.7K and leaving 196,335 shares worth $3.09M. The position accounts for 0.03% of the portfolio, ranked #501.
Oppenheimer & Co first reported a position in ECAT in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.87M in Q3 2024. 79 funds tracked by Wall St. Rank hold ECAT as of Q2 2026.
- Oppenheimer & Co held 196,335 shares of BlackRock ESG Capital Allocation Term Trust worth $3.09M as of Q2 2026.
- Oppenheimer & Co sold 2,896 BlackRock ESG Capital Allocation Term Trust shares in Q2 2026, an estimated $43.7K.
- BlackRock ESG Capital Allocation Term Trust made up 0.03% of Oppenheimer & Co's portfolio in Q2 2026, its #501 holding.
- Oppenheimer & Co first reported a position in BlackRock ESG Capital Allocation Term Trust in Q4 2022 and has held it in 15 quarters since.
- Oppenheimer & Co's BlackRock ESG Capital Allocation Term Trust position peaked at $4.87M in Q3 2024.
- 79 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q2 2026.
Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.